Levi & Korsinsky, LLP Announces Investigation of Kayak Software
Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class
Action Against Questcor Pharmaceuticals, Inc. (QCOR) and Peregrine
Pharmaceuticals, Inc. (PPHM)
NEW YORK, Nov. 20, 2012 /PRNewswire/ --
(Logo:
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
Kayak Software Corporation
Levi & Korsinsky is
investigating the Board of Directors of Kayak Software Corporation
(NasdaqGS: KYAK) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to priceline.com Incorporated (NasdaqGS: PCLN) under which
shareholders would receive cash and stock valued at approximately
$40 per share.
Click here to learn more about the investigation:
http://zlk.9nl.com/kayak-software-kyak, or call:
877-363-5972.
JDA Software Group Inc.
Levi & Korsinsky is
investigating the Board of Directors of JDA Software Group Inc.
(NasdaqGS: JDAS) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to RedPrairie Corp. for $45 per
share.
Click here to learn more about the investigation
http://zlk.9nl.com/jda-software, or call: 877-363-5972.
Questcor Pharmaceuticals, Inc.
Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
USDC for the Central District of California on behalf of investors who acquired
Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between
April 26, 2011 and September 21, 2012.
For more information, click here:
http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have
until November 26, 2012 to request
that the Court appoint you as lead plaintiff.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
USDC for the Central District of California on behalf of investors who acquired
Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between
August 30, 2012 and September 26, 2012.
For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You
have until November 27, 2012 to
request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in
New York and Washington D.C.
The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP